Your browser doesn't support javascript.
loading
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series.
Nakamura, Hideta; Miyagi, Kazuya; Otsuki, Mariko; Higure, Yuuri; Nishiyama, Naoya; Kinjo, Takeshi; Nakamatsu, Masashi; Haranaga, Shusaku; Tateyama, Masao; Fujita, Jiro.
Affiliation
  • Nakamura H; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan. Electronic address: hnnakamu@med.u-ryukyu.ac.jp.
  • Miyagi K; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Otsuki M; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Higure Y; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Nishiyama N; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Kinjo T; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Nakamatsu M; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Haranaga S; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Tateyama M; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
  • Fujita J; Department of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus, Graduate School of Medicine, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.
Respir Investig ; 58(6): 510-512, 2020 11.
Article in En | MEDLINE | ID: mdl-33067149
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Interleukin-6 / Antibodies, Monoclonal, Humanized / Cytokine Release Syndrome / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: Asia Language: En Journal: Respir Investig Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Interleukin-6 / Antibodies, Monoclonal, Humanized / Cytokine Release Syndrome / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: Asia Language: En Journal: Respir Investig Year: 2020 Document type: Article Country of publication: